Risk prediction models for cardiac rupture after acute myocardial infarction: a systematic review and meta-analysis

Yijun Mao1, Qiang Liu2, Hui Fan1

  • 1Department of Nursing, Xianyang Central Hospital, Xianyang, Shaanxi, China.

PubMed

Insights

Cardiac rupture after acute myocardial infarction is a serious risk. Existing prediction models show promise but have flaws. Robust predictors like age and sex should guide future risk stratification tools.

Area of Science:

  • Cardiovascular Medicine
  • Medical Statistics
  • Clinical Epidemiology

Background:

  • Cardiac rupture (CR) is a severe complication of acute myocardial infarction (AMI), contributing significantly to mortality.
  • Existing risk prediction models for CR post-AMI have uncertain methodological quality and clinical applicability.

Purpose of the Study:

  • To systematically review and quantitatively synthesize existing risk prediction models for CR following AMI.
  • To assess the methodological quality and clinical applicability of current CR prediction models.

Main Methods:

  • Comprehensive literature search of multiple databases (PubMed, Embase, Web of Science, etc.) up to August 2025.
  • Data extraction using CHARMS checklist and methodological quality assessment with PROBAST.
  • Meta-analysis of model discrimination (C-statistic) and predictor evaluation, with subgroup analyses for heterogeneity.

Main Results:

  • Ten studies (2017-2024) were included, with nine suitable for meta-analysis.
  • The pooled C-statistic for CR prediction models was 0.83 (95% CI: 0.78-0.89), indicating good discriminatory ability but high heterogeneity.
  • Robust predictors identified include advanced age, female sex, higher Killip grade, elevated heart rate, lower LVEF, and absence of emergency PCI. Methodological flaws were common.

Conclusions:

  • Current CR prediction models show promising discriminatory power but suffer from significant methodological limitations.
  • Key predictors such as age, sex, Killip grade, LVEF, and PCI status should inform the development of future consensus-based models.
  • There is an urgent need for large-scale, prospective, and externally validated studies to create reliable clinical risk stratification tools for CR prevention.
Abstract